(Q43930950)

28 November 2017

title

Antitumoral effects of recombinant adenovirus YKL-1001, conditionally replicating in alpha-fetoprotein-producing human liver cancer cells (English)

1 reference

28 November 2017

1 reference

1 reference

4

1 reference

28 November 2017

Jaesung Kim

1

1 reference

28 November 2017

Boyoung Lee

2

1 reference

28 November 2017

Jin Seok Kim

3

1 reference

28 November 2017

Joo Hang Kim

5

1 reference

28 November 2017

Yong J Lee

6

1 reference

28 November 2017

Chul Hyun Joo

7

1 reference

28 November 2017

Heuiran Lee

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

180

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

23-32

1 reference

28 November 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Gene therapy of viral hepatitis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

The potential of gene therapy in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Gene therapy for liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Treatment of hepatocellular carcinoma: too many options?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Nonsurgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Cancer gene therapy: hard lessons and new courses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Gene therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Adenovirus vectors for high-efficiency gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Adenovirus-mediated gene transfer into human hepatocytes: analysis of the biochemical functionality of transduced cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Cancer gene therapy annual conference 1997: trends and news

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

ONYX-015: clinical data are encouraging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Oncolytic potential of E1B 55 kDa-deleted YKL-1 recombinant adenovirus: correlation with p53 functional status

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Adenovirus lacking the 19-kDa and 55-kDa E1B genes exerts a marked cytotoxic effect in human malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900017-4

7 January 2021

10.1016/S0304-3835(02)00017-4

Identifiers

DOI

1 reference

28 November 2017

1 reference